drugset / Trial / NCT03967730
Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) in reducing the inflammation of perivascular adipose tissue and increasing peak walking time (PWT) among peripheral artery disease (PAD) patients with symptom of intermittent claudication.
Timeline
- Start
- 2019-06-20
- Primary completion
- 2020-05-30
- Completion
- 2020-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinoporphyrin sodium | Other / unclassified | 0.2 mg/kg | Intravenous |